drug

emraclidine

1 story · latest Aug 21, 2026

Status: Investigational
Codes: ABBV-1231, CVL-231
Trials: 4 registered trials in coverage

Relationships

Developed by AbbVie

Timeline

AbbVie posts results from terminated emraclidine trial, opens two studies to recruitment

Aug 21Weekly roundup, 4 itemsAbbVie emraclidine

Biotech intelligence from primary sources. Every story is an original summary of a public record, linked to its source. Not investment advice.

Terms Privacy hello@readthrough.news

readthrough is a product of JAMN Ventures, LLC.